-
A Congressional Briefing on Increasing Inventor Diversity Posted on by Jennifer Brant in Inclusive Innovation Ecosystems
-
‘To be a scientist is a joy’: How a Hungarian biochemist helped revolutionize mRNA Posted on by Jennifer Brant in Innovation and the Sustainable Development Goals
-
Australia’s medical innovation approach: Is it suitable for regenerative medicine? Posted on by Jennifer Brant in Innovation and the Sustainable Development Goals
-
What it would mean for big Pharma if Vaccine IP Rights are waived Posted on by Jennifer Brant in Innovation and the Sustainable Development Goals
-
How healthcare innovation presents a ‘compelling universe of choices’ for investors Posted on by Jennifer Brant in Innovation and the Sustainable Development Goals
-
Here’s why developing countries can make COVID-19 mRNA vaccines Posted on by Jennifer Brant in Innovation and the Sustainable Development Goals
-
How Technology is Reshaping the IP Management Industry Posted on by Jennifer Brant in Technology and Knowledge Diffusion
-
Internal culture: The hidden barrier to innovation in healthcare Posted on by Jennifer Brant in Innovation and the Sustainable Development Goals
-
Protecting U.S. Intellectual Property & Innovation Leadership: December 16, 2021 Posted on by Jennifer Brant in Policy Discussions and International Organizations
-
South African Company nears License to sell J. & J. Covid Shot across Africa Posted on by Jennifer Brant in Enabling Innovation Policies
-
Artificial intelligence-created medicine to be used on humans for first time Posted on by Jennifer Brant in Innovation and the Sustainable Development Goals
-
5G IP makes best with Patent Platform and Technology Investment Posted on by Jennifer Brant in Technology and Knowledge Diffusion